APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Medical Blood Transfusion

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Medical Blood Transfusion Market Outlook and Growth Opportunities 2026

Report ID 174010680426 December 2025190 pages

Choose your research edition.

Industry ResearchMedical Blood Transfusion Industry Research Report 2026128 pages · $2,950 USDIndustry Growth & TrendsGlobal Medical Blood Transfusion Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Medical Blood Transfusion Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Medical Blood Transfusion Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Medical Blood Transfusion Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Medical Blood Transfusion market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Medical Blood Transfusion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Medical Blood Transfusion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Medical Blood Transfusion is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Medical Blood Transfusion market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Medical Blood Transfusion market include Suzhou Laishi, B.Braun, Welford Manufacturing, Wego, Vogt Medical, TERUMO, JMS Co., Helm Medical and Grifols, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Medical Blood Transfusion market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Medical Blood Transfusion and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Medical Blood Transfusion sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Medical Blood Transfusion market size, projected growth trends, production technologies, key applications, and end-use industries.

Medical Blood Transfusion Segment by Company

Suzhou Laishi

B.Braun

Welford Manufacturing

Wego

Vogt Medical

TERUMO

JMS Co.

Helm Medical

Grifols

GAMA GROUP

Fresenius Kabi

Medical Blood Transfusion Segment by Type

Straight blood transfusion set

Y-type blood transfusion

Others

Medical Blood Transfusion Segment by Application

Child

Adult

Medical Blood Transfusion Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Medical Blood Transfusion status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Medical Blood Transfusion market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Medical Blood Transfusion significant trends, drivers, influence factors in global and regions.

6. To analyze Medical Blood Transfusion competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Medical Blood Transfusion market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Medical Blood Transfusion and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Medical Blood Transfusion.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Medical Blood Transfusion market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Medical Blood Transfusion industry.

Chapter 3: Detailed analysis of Medical Blood Transfusion manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Medical Blood Transfusion in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Medical Blood Transfusion in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Medical Blood Transfusion Industry Trends Table 2. Medical Blood Transfusion Industry Drivers Table 3. Medical Blood Transfusion Industry Opportunities and Challenges Table 4. Medical Blood Transfusion Industry Restraints Table 5. Global Medical Blood Transfusion Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Medical Blood Transfusion Revenue Share by Company (2021-2026) Table 7. Global Medical Blood Transfusion Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Medical Blood Transfusion Sales Volume Share by Company (2021-2026) Table 9. Global Medical Blood Transfusion Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Medical Blood Transfusion Company Ranking, (2024-2026) & (USD Million) Table 11. Global Medical Blood Transfusion Key Company Manufacturing Base & Headquarters Table 12. Global Medical Blood Transfusion Company, Product Type & Application Table 13. Global Medical Blood Transfusion Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Medical Blood Transfusion by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Straight blood transfusion set Table 18. Significant Companies of Y-type blood transfusion Table 19. Significant Companies of Others Table 20. Global Medical Blood Transfusion Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 21. Global Medical Blood Transfusion Sales Volume by Type (2021-2026) & (W Units) Table 22. Global Medical Blood Transfusion Sales Volume by Type (2027-2032) & (W Units) Table 23. Global Medical Blood Transfusion Sales Volume Share by Type (2021-2026) Table 24. Global Medical Blood Transfusion Sales Volume Share by Type (2027-2032) Table 25. Global Medical Blood Transfusion Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Medical Blood Transfusion Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Medical Blood Transfusion Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Medical Blood Transfusion Sales Value Share by Type (2021-2026) Table 29. Global Medical Blood Transfusion Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Child Table 31. Significant Companies of Adult Table 32. Global Medical Blood Transfusion Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Medical Blood Transfusion Sales Volume by Application (2021-2026) & (W Units) Table 34. Global Medical Blood Transfusion Sales Volume by Application (2027-2032) & (W Units) Table 35. Global Medical Blood Transfusion Sales Volume Share by Application (2021-2026) Table 36. Global Medical Blood Transfusion Sales Volume Share by Application (2027-2032) Table 37. Global Medical Blood Transfusion Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Medical Blood Transfusion Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Medical Blood Transfusion Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Medical Blood Transfusion Sales Value Share by Application (2021-2026) Table 41. Global Medical Blood Transfusion Sales Value Share by Application (2027-2032) Table 42. Global Medical Blood Transfusion Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Medical Blood Transfusion Sales by Region (2021-2026) & (W Units) Table 44. Global Medical Blood Transfusion Sales Market Share by Region (2021-2026) Table 45. Global Medical Blood Transfusion Sales by Region (2027-2032) & (W Units) Table 46. Global Medical Blood Transfusion Sales Market Share by Region (2027-2032) Table 47. Global Medical Blood Transfusion Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Medical Blood Transfusion Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Medical Blood Transfusion Sales Value Share by Region (2021-2026) Table 50. Global Medical Blood Transfusion Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Medical Blood Transfusion Sales Value Share by Region (2027-2032) Table 52. Global Medical Blood Transfusion Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Medical Blood Transfusion Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Medical Blood Transfusion Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 55. Global Medical Blood Transfusion Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Medical Blood Transfusion Sales by Country (2021-2026) & (W Units) Table 57. Global Medical Blood Transfusion Sales Market Share by Country (2021-2026) Table 58. Global Medical Blood Transfusion Sales by Country (2027-2032) & (W Units) Table 59. Global Medical Blood Transfusion Sales Market Share by Country (2027-2032) Table 60. Global Medical Blood Transfusion Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Medical Blood Transfusion Sales Value Market Share by Country (2021-2026) Table 62. Global Medical Blood Transfusion Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Medical Blood Transfusion Sales Value Market Share by Country (2027-2032) Table 64. Suzhou Laishi Company Information Table 65. Suzhou Laishi Business Overview Table 66. Suzhou Laishi Medical Blood Transfusion Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Suzhou Laishi Medical Blood Transfusion Product Portfolio Table 68. Suzhou Laishi Recent Development Table 69. B.Braun Company Information Table 70. B.Braun Business Overview Table 71. B.Braun Medical Blood Transfusion Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. B.Braun Medical Blood Transfusion Product Portfolio Table 73. B.Braun Recent Development Table 74. Welford Manufacturing Company Information Table 75. Welford Manufacturing Business Overview Table 76. Welford Manufacturing Medical Blood Transfusion Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Welford Manufacturing Medical Blood Transfusion Product Portfolio Table 78. Welford Manufacturing Recent Development Table 79. Wego Company Information Table 80. Wego Business Overview Table 81. Wego Medical Blood Transfusion Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Wego Medical Blood Transfusion Product Portfolio Table 83. Wego Recent Development Table 84. Vogt Medical Company Information Table 85. Vogt Medical Business Overview Table 86. Vogt Medical Medical Blood Transfusion Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Vogt Medical Medical Blood Transfusion Product Portfolio Table 88. Vogt Medical Recent Development Table 89. TERUMO Company Information Table 90. TERUMO Business Overview Table 91. TERUMO Medical Blood Transfusion Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. TERUMO Medical Blood Transfusion Product Portfolio Table 93. TERUMO Recent Development Table 94. JMS Co. Company Information Table 95. JMS Co. Business Overview Table 96. JMS Co. Medical Blood Transfusion Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. JMS Co. Medical Blood Transfusion Product Portfolio Table 98. JMS Co. Recent Development Table 99. Helm Medical Company Information Table 100. Helm Medical Business Overview Table 101. Helm Medical Medical Blood Transfusion Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Helm Medical Medical Blood Transfusion Product Portfolio Table 103. Helm Medical Recent Development Table 104. Grifols Company Information Table 105. Grifols Business Overview Table 106. Grifols Medical Blood Transfusion Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Grifols Medical Blood Transfusion Product Portfolio Table 108. Grifols Recent Development Table 109. GAMA GROUP Company Information Table 110. GAMA GROUP Business Overview Table 111. GAMA GROUP Medical Blood Transfusion Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. GAMA GROUP Medical Blood Transfusion Product Portfolio Table 113. GAMA GROUP Recent Development Table 114. Fresenius Kabi Company Information Table 115. Fresenius Kabi Business Overview Table 116. Fresenius Kabi Medical Blood Transfusion Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Fresenius Kabi Medical Blood Transfusion Product Portfolio Table 118. Fresenius Kabi Recent Development Table 119. Key Raw Materials Table 120. Raw Materials Key Suppliers Table 121. Medical Blood Transfusion Distributors List Table 122. Medical Blood Transfusion Customers List Table 123. Research Programs/Design for This Report Table 124. Authors List of This Report Table 125. Secondary Sources Table 126. Primary Sources List of Figures Figure 1. Medical Blood Transfusion Product Image Figure 2. Global Medical Blood Transfusion Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Medical Blood Transfusion Sales Value (2021-2032) & (US$ Million) Figure 4. Global Medical Blood Transfusion Sales (2021-2032) & (W Units) Figure 5. Global Medical Blood Transfusion Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Medical Blood Transfusion Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Straight blood transfusion set Image Figure 10. Y-type blood transfusion Image Figure 11. Others Image Figure 12. Global Medical Blood Transfusion Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 13. Global Medical Blood Transfusion Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Medical Blood Transfusion Sales Volume Share by Type (2021-2032) Figure 15. Global Medical Blood Transfusion Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Medical Blood Transfusion Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Medical Blood Transfusion Sales Value Share by Type (2021-2032) Figure 18. Child Image Figure 19. Adult Image Figure 20. Global Medical Blood Transfusion Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Medical Blood Transfusion Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Medical Blood Transfusion Sales Volume Share by Application (2021-2032) Figure 23. Global Medical Blood Transfusion Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Medical Blood Transfusion Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Medical Blood Transfusion Sales Value Share by Application (2021-2032) Figure 26. Global Medical Blood Transfusion Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 27. Global Medical Blood Transfusion Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Medical Blood Transfusion Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Medical Blood Transfusion Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Medical Blood Transfusion Sales Value (2021-2032) & (US$ Million) Figure 31. North America Medical Blood Transfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Medical Blood Transfusion Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Medical Blood Transfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Medical Blood Transfusion Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Medical Blood Transfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Medical Blood Transfusion Sales Value (2021-2032) & (US$ Million) Figure 37. South America Medical Blood Transfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Medical Blood Transfusion Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Medical Blood Transfusion Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Medical Blood Transfusion Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Medical Blood Transfusion Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Medical Blood Transfusion Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Straight blood transfusion set
  • Y-type blood transfusion
  • Others
Applications
  • Child
  • Adult
Companies covered
  • Suzhou Laishi
  • B.Braun
  • Welford Manufacturing
  • Wego
  • Vogt Medical
  • TERUMO
  • JMS Co.
  • Helm Medical
  • Grifols
  • GAMA GROUP
  • Fresenius Kabi

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Medical Blood Transfusion Sales Value (2021-2032)
  4. 1.2.2 Global Medical Blood Transfusion Sales Volume (2021-2032)
  5. 1.2.3 Global Medical Blood Transfusion Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Medical Blood Transfusion Market Dynamics
  1. 2.1 Medical Blood Transfusion Industry Trends
  2. 2.2 Medical Blood Transfusion Industry Drivers
  3. 2.3 Medical Blood Transfusion Industry Opportunities and Challenges
  4. 2.4 Medical Blood Transfusion Industry Restraints
3 Medical Blood Transfusion Market by Company
  1. 3.1 Global Medical Blood Transfusion Company Revenue Ranking in 2025
  2. 3.2 Global Medical Blood Transfusion Revenue by Company (2021-2026)
  3. 3.3 Global Medical Blood Transfusion Sales Volume by Company (2021-2026)
  4. 3.4 Global Medical Blood Transfusion Average Price by Company (2021-2026)
  5. 3.5 Global Medical Blood Transfusion Company Ranking (2024-2026)
  6. 3.6 Global Medical Blood Transfusion Company Manufacturing Base and Headquarters
  7. 3.7 Global Medical Blood Transfusion Company Product Type and Application
  8. 3.8 Global Medical Blood Transfusion Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Medical Blood Transfusion Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Medical Blood Transfusion Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Medical Blood Transfusion Market by Type
  1. 4.1 Medical Blood Transfusion Type Introduction
  2. 4.1.1 Straight blood transfusion set
  3. 4.1.2 Y-type blood transfusion
  4. 4.1.3 Others
  5. 4.2 Global Medical Blood Transfusion Sales Volume by Type
  6. 4.2.1 Global Medical Blood Transfusion Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Medical Blood Transfusion Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Medical Blood Transfusion Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Medical Blood Transfusion Sales Value by Type
  10. 4.3.1 Global Medical Blood Transfusion Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Medical Blood Transfusion Sales Value by Type (2021-2032)
  12. 4.3.3 Global Medical Blood Transfusion Sales Value Share by Type (2021-2032)
5 Medical Blood Transfusion Market by Application
  1. 5.1 Medical Blood Transfusion Application Introduction
  2. 5.1.1 Child
  3. 5.1.2 Adult
  4. 5.2 Global Medical Blood Transfusion Sales Volume by Application
  5. 5.2.1 Global Medical Blood Transfusion Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Medical Blood Transfusion Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Medical Blood Transfusion Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Medical Blood Transfusion Sales Value by Application
  9. 5.3.1 Global Medical Blood Transfusion Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Medical Blood Transfusion Sales Value by Application (2021-2032)
  11. 5.3.3 Global Medical Blood Transfusion Sales Value Share by Application (2021-2032)
6 Medical Blood Transfusion Regional Sales and Value Analysis
  1. 6.1 Global Medical Blood Transfusion Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Medical Blood Transfusion Sales by Region (2021-2032)
  3. 6.2.1 Global Medical Blood Transfusion Sales by Region: 2021-2026
  4. 6.2.2 Global Medical Blood Transfusion Sales by Region (2027-2032)
  5. 6.3 Global Medical Blood Transfusion Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Medical Blood Transfusion Sales Value by Region (2021-2032)
  7. 6.4.1 Global Medical Blood Transfusion Sales Value by Region: 2021-2026
  8. 6.4.2 Global Medical Blood Transfusion Sales Value by Region (2027-2032)
  9. 6.5 Global Medical Blood Transfusion Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Medical Blood Transfusion Sales Value (2021-2032)
  12. 6.6.2 North America Medical Blood Transfusion Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Medical Blood Transfusion Sales Value (2021-2032)
  15. 6.7.2 Europe Medical Blood Transfusion Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Medical Blood Transfusion Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Medical Blood Transfusion Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Medical Blood Transfusion Sales Value (2021-2032)
  21. 6.9.2 South America Medical Blood Transfusion Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Medical Blood Transfusion Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Medical Blood Transfusion Sales Value Share by Country, 2025 VS 2032
7 Medical Blood Transfusion Country-level Sales and Value Analysis
  1. 7.1 Global Medical Blood Transfusion Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Medical Blood Transfusion Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Medical Blood Transfusion Sales by Country (2021-2032)
  4. 7.3.1 Global Medical Blood Transfusion Sales by Country (2021-2026)
  5. 7.3.2 Global Medical Blood Transfusion Sales by Country (2027-2032)
  6. 7.4 Global Medical Blood Transfusion Sales Value by Country (2021-2032)
  7. 7.4.1 Global Medical Blood Transfusion Sales Value by Country (2021-2026)
  8. 7.4.2 Global Medical Blood Transfusion Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Medical Blood Transfusion Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Medical Blood Transfusion Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Medical Blood Transfusion Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Suzhou Laishi
  2. 8.1.1 Suzhou Laishi Company Information
  3. 8.1.2 Suzhou Laishi Business Overview
  4. 8.1.3 Suzhou Laishi Medical Blood Transfusion Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Suzhou Laishi Medical Blood Transfusion Product Portfolio
  6. 8.1.5 Suzhou Laishi Recent Developments
  7. 8.2 B.Braun
  8. 8.2.1 B.Braun Company Information
  9. 8.2.2 B.Braun Business Overview
  10. 8.2.3 B.Braun Medical Blood Transfusion Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 B.Braun Medical Blood Transfusion Product Portfolio
  12. 8.2.5 B.Braun Recent Developments
  13. 8.3 Welford Manufacturing
  14. 8.3.1 Welford Manufacturing Company Information
  15. 8.3.2 Welford Manufacturing Business Overview
  16. 8.3.3 Welford Manufacturing Medical Blood Transfusion Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Welford Manufacturing Medical Blood Transfusion Product Portfolio
  18. 8.3.5 Welford Manufacturing Recent Developments
  19. 8.4 Wego
  20. 8.4.1 Wego Company Information
  21. 8.4.2 Wego Business Overview
  22. 8.4.3 Wego Medical Blood Transfusion Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Wego Medical Blood Transfusion Product Portfolio
  24. 8.4.5 Wego Recent Developments
  25. 8.5 Vogt Medical
  26. 8.5.1 Vogt Medical Company Information
  27. 8.5.2 Vogt Medical Business Overview
  28. 8.5.3 Vogt Medical Medical Blood Transfusion Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Vogt Medical Medical Blood Transfusion Product Portfolio
  30. 8.5.5 Vogt Medical Recent Developments
  31. 8.6 TERUMO
  32. 8.6.1 TERUMO Company Information
  33. 8.6.2 TERUMO Business Overview
  34. 8.6.3 TERUMO Medical Blood Transfusion Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 TERUMO Medical Blood Transfusion Product Portfolio
  36. 8.6.5 TERUMO Recent Developments
  37. 8.7 JMS Co.
  38. 8.7.1 JMS Co. Company Information
  39. 8.7.2 JMS Co. Business Overview
  40. 8.7.3 JMS Co. Medical Blood Transfusion Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 JMS Co. Medical Blood Transfusion Product Portfolio
  42. 8.7.5 JMS Co. Recent Developments
  43. 8.8 Helm Medical
  44. 8.8.1 Helm Medical Company Information
  45. 8.8.2 Helm Medical Business Overview
  46. 8.8.3 Helm Medical Medical Blood Transfusion Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Helm Medical Medical Blood Transfusion Product Portfolio
  48. 8.8.5 Helm Medical Recent Developments
  49. 8.9 Grifols
  50. 8.9.1 Grifols Company Information
  51. 8.9.2 Grifols Business Overview
  52. 8.9.3 Grifols Medical Blood Transfusion Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Grifols Medical Blood Transfusion Product Portfolio
  54. 8.9.5 Grifols Recent Developments
  55. 8.10 GAMA GROUP
  56. 8.10.1 GAMA GROUP Company Information
  57. 8.10.2 GAMA GROUP Business Overview
  58. 8.10.3 GAMA GROUP Medical Blood Transfusion Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 GAMA GROUP Medical Blood Transfusion Product Portfolio
  60. 8.10.5 GAMA GROUP Recent Developments
  61. 8.11 Fresenius Kabi
  62. 8.11.1 Fresenius Kabi Company Information
  63. 8.11.2 Fresenius Kabi Business Overview
  64. 8.11.3 Fresenius Kabi Medical Blood Transfusion Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Fresenius Kabi Medical Blood Transfusion Product Portfolio
  66. 8.11.5 Fresenius Kabi Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Medical Blood Transfusion Value Chain Analysis
  2. 9.1.1 Medical Blood Transfusion Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Medical Blood Transfusion Sales Mode & Process
  6. 9.2 Medical Blood Transfusion Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Medical Blood Transfusion Distributors
  9. 9.2.3 Medical Blood Transfusion Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst